Ruhl H G, Hölig K
Abteilung Transfusionsmedizin, Universitätsklinikum Carl Gustav Carus der TU Dresden, Deutschland.
Beitr Infusionsther Transfusionsmed. 1996;33:210-4.
In a retrospective study 152 children and adolescents were selected from a collective of 3017 patients who participated in a predeposited autologous blood program from 1991 to 1995. 107 patients were female and 45 male. Average age was 14.4 years (range 6-18 years) and the body weights ranged from 27 to 79 kg. 90% underwent orthopedic surgery, 53% for scoliosis. Patients donated altogether 366 transfusion units (TE), an average of 2.4 TE was performed on each patient. Male patients had a higher level of hemoglobin than female and yielded the 4 autologous blood donations 5 days before female patients. Operation and hospitalization were completed by 44% without receiving any homologous blood, and 17% of patients needed only 1 homologous blood donation in addition to autologous blood. Preoperative blood donation led to no significant complications. We conclude that the autologous blood program is an effective and safe means of blood replacement, and is suitable for use in children and adolescents.
在一项回顾性研究中,从1991年至1995年参与预存自体血计划的3017名患者中选取了152名儿童和青少年。其中107例为女性,45例为男性。平均年龄为14.4岁(范围6 - 18岁),体重范围为27至79千克。90%的患者接受了骨科手术,其中53%是因脊柱侧弯。患者共捐献了366个输血单位(TE),每位患者平均进行了2.4次TE采集。男性患者的血红蛋白水平高于女性,且比女性患者提前5天进行了4次自体血捐献。44%的患者在未接受任何异体血的情况下完成了手术和住院治疗,17%的患者除自体血外仅需1次异体血输注。术前献血未导致明显并发症。我们得出结论,自体血计划是一种有效且安全的血液替代方法,适用于儿童和青少年。